What could have saved the Bharti Airtel-MTN deal?

Bharti Airtel and MTN were unable to convince the South African government to accept their cross-border merger proposal. The government did not object to the merger per se but to the structure, which was outside the current regulatory environment. The two companies had proposed a structure, which ostensibly involved MTN taking up a stake in Bharti by subscribing to ADRs/GDRs. Bharti would in turn take up a stake in MTN, which was a direct transaction.
 

Continue Reading

Bharti Airtel and MTN can’t seem to decide

Bharti Airtel and MTN have still not managed to get their merger act together and don’t expect to do so any time soon. They have 10 days to go for the August 31 deadline for exclusive talks to end. But Bharti Airtel today announced an extension of talks till September 30. It is unlikely that the two sides are not able to agree on the price, by now they would have called off the talks if price was a sore point
 

Continue Reading

DIL sells drug discovery and development services subsidiary to Evotec AG

DIL is selling a 70% stake in its contract research subsidiary to a European company Evotec AG, headquartered in Germany. DIL was earlier known as Duphar Interfran and it changed its name after its pharmaceutical business was hived off to Solvay. Of its consolidated turnover of Rs 70 crore in 2008-09, bulk drugs/chemicals contributed to over half, while research and development contributed to about a third at Rs 22 crore.
 

Continue Reading